SGM-101 is safe and effective for intraoperative imaging of pancreatic ductal adenocarcinoma Sep. 28, 2018 No Comments
Integrin alphaVbeta6 PET tracer shows promise for assessment of interstitial lung disease Sep. 17, 2018 No Comments
Progenics reports topline phase III data on 1404 in low-grade prostate cancer Sep. 13, 2018 No Comments
Phase III study of PET imaging agent flortaucipir F 18 meets primary endpoints Sep. 6, 2018 No Comments
Telix submits CTA to begin phase III trial in Europe with TLX-250 for renal cancer imaging Aug. 24, 2018 No Comments